Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies. [electronic resource]
Producer: 20131021Description: 1628-36 p. digitalISSN:- 1476-5551
- Acetylation
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Drug Administration Schedule
- Female
- Hematologic Neoplasms -- diagnosis
- Histone Deacetylase Inhibitors -- administration & dosage
- Histones -- metabolism
- Humans
- Hydroxamic Acids -- administration & dosage
- Indoles -- administration & dosage
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Staging
- Panobinostat
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.